摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(+/-)-2-(5-methoxy-2,3-dihydrobenzofuran-3-yl)ethanol | 589091-11-2

中文名称
——
中文别名
——
英文名称
(+/-)-2-(5-methoxy-2,3-dihydrobenzofuran-3-yl)ethanol
英文别名
2-(5-Methoxy-2,3-dihydro-1-benzofuran-3-yl)ethanol
(+/-)-2-(5-methoxy-2,3-dihydrobenzofuran-3-yl)ethanol化学式
CAS
589091-11-2
化学式
C11H14O3
mdl
——
分子量
194.23
InChiKey
ZOOFPGLEDYARHZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    297.5±33.0 °C(Predicted)
  • 密度:
    1.151±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    14
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    38.7
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis and Pharmacological Characterization of a Series of Geometrically Constrained 5-HT2A/2C Receptor Ligands
    摘要:
    In studies of the SAR of phenethylamine-type serotonin 5-HT2A receptor agonists, substituted conformationally constrained tetrahydronaphthofurans were designed to investigate the optimal conformation of the 2-aminoethyl moiety. These compounds were tested using in vitro assays for affinity at 5-HT1A, 5-HT2A, and 5-HT2C receptors. The benzofuran-containing analogues, 6a and 6b, had significantly higher affinity for the 5-HT receptors tested than did the benzodi-hydrofuran-containing compounds, 4a, 4b, 5a, and 5b. The most potent compound (8-bromo-6-methoxy-4,5-dihydro-3H-naphtho[1,8-bc]furan-5-yl)aminomethane, 6b, had K-i values for displacement of [I-125] -DOI from 5-HT2A and 5-HT2C cloned rat receptors of 2.6 and 1.1 nM, respectively. Despite their high affinity, the compounds of this naphthofuran series lacked high intrinsic activity at the 5-HT2A receptor as measured using the phosphoinositide hydrolysis assay. The most potent compound in vitro, 6b, was tested in the two-lever drug discrimination assay in rats trained to discriminate LSD from saline, and failed to substitute, a result typical for compounds with low intrinsic activity. Thus, although conformational constraint has led to high-affinity 5-HT2A ligands with partial agonist activity, all of the spatial and steric properties of the ligand necessary for full receptor activation have not yet been identified.
    DOI:
    10.1021/jm030064v
  • 作为产物:
    描述:
    4-甲氧基苯酚 在 lithium aluminium tetrahydride 、 偶氮二异丁腈三正丁基氢锡potassium carbonate 、 potassium iodide 作用下, 以 甲醇乙醚丙酮 为溶剂, 反应 18.0h, 生成 (+/-)-2-(5-methoxy-2,3-dihydrobenzofuran-3-yl)ethanol
    参考文献:
    名称:
    Synthesis and Pharmacological Characterization of a Series of Geometrically Constrained 5-HT2A/2C Receptor Ligands
    摘要:
    In studies of the SAR of phenethylamine-type serotonin 5-HT2A receptor agonists, substituted conformationally constrained tetrahydronaphthofurans were designed to investigate the optimal conformation of the 2-aminoethyl moiety. These compounds were tested using in vitro assays for affinity at 5-HT1A, 5-HT2A, and 5-HT2C receptors. The benzofuran-containing analogues, 6a and 6b, had significantly higher affinity for the 5-HT receptors tested than did the benzodi-hydrofuran-containing compounds, 4a, 4b, 5a, and 5b. The most potent compound (8-bromo-6-methoxy-4,5-dihydro-3H-naphtho[1,8-bc]furan-5-yl)aminomethane, 6b, had K-i values for displacement of [I-125] -DOI from 5-HT2A and 5-HT2C cloned rat receptors of 2.6 and 1.1 nM, respectively. Despite their high affinity, the compounds of this naphthofuran series lacked high intrinsic activity at the 5-HT2A receptor as measured using the phosphoinositide hydrolysis assay. The most potent compound in vitro, 6b, was tested in the two-lever drug discrimination assay in rats trained to discriminate LSD from saline, and failed to substitute, a result typical for compounds with low intrinsic activity. Thus, although conformational constraint has led to high-affinity 5-HT2A ligands with partial agonist activity, all of the spatial and steric properties of the ligand necessary for full receptor activation have not yet been identified.
    DOI:
    10.1021/jm030064v
点击查看最新优质反应信息

文献信息

  • Synthesis and Pharmacological Characterization of a Series of Geometrically Constrained 5-HT<sub>2A/2C</sub> Receptor Ligands
    作者:James J. Chambers、Jason C. Parrish、Niels H. Jensen、Deborah M. Kurrasch-Orbaugh、Danuta Marona-Lewicka、David E. Nichols
    DOI:10.1021/jm030064v
    日期:2003.7.1
    In studies of the SAR of phenethylamine-type serotonin 5-HT2A receptor agonists, substituted conformationally constrained tetrahydronaphthofurans were designed to investigate the optimal conformation of the 2-aminoethyl moiety. These compounds were tested using in vitro assays for affinity at 5-HT1A, 5-HT2A, and 5-HT2C receptors. The benzofuran-containing analogues, 6a and 6b, had significantly higher affinity for the 5-HT receptors tested than did the benzodi-hydrofuran-containing compounds, 4a, 4b, 5a, and 5b. The most potent compound (8-bromo-6-methoxy-4,5-dihydro-3H-naphtho[1,8-bc]furan-5-yl)aminomethane, 6b, had K-i values for displacement of [I-125] -DOI from 5-HT2A and 5-HT2C cloned rat receptors of 2.6 and 1.1 nM, respectively. Despite their high affinity, the compounds of this naphthofuran series lacked high intrinsic activity at the 5-HT2A receptor as measured using the phosphoinositide hydrolysis assay. The most potent compound in vitro, 6b, was tested in the two-lever drug discrimination assay in rats trained to discriminate LSD from saline, and failed to substitute, a result typical for compounds with low intrinsic activity. Thus, although conformational constraint has led to high-affinity 5-HT2A ligands with partial agonist activity, all of the spatial and steric properties of the ligand necessary for full receptor activation have not yet been identified.
查看更多

同类化合物

黄曲霉毒素 D1 顺式-3alpha,8alpha-二氢-4,6-二甲氧基-呋喃并[2,3-b]苯并呋喃 阿莫拉酮 苯甲醇,-α--甲基-4-(2-甲基丙基)-,乙酸酯(9CI) 苯并呋喃,7-氯-2,3-二氢-2,2-二甲基- 苯并呋喃,4-氯-2,3-二氢- 苯并呋喃,2,3-二氢-3-[(苯基硫代)甲基]- 苯并二氢呋喃-4-甲醛 苯并二氢呋喃-4-甲酸 苯并二氢呋喃-2-羧酸 胆甾-8-烯-3,15-二醇,(3b,5a,15a)-(9CI) 盐酸依法洛沙 甲基氨基甲酸4-氯-2,3-二氢-2,2-二甲基苯并呋喃-7-基酯 甲基5-氨基-2,3-二氢-1-苯并呋喃-2-羧酸酯 甲基2-乙基-6-羟基-2,3-二氢-1-苯并呋喃-2-羧酸酯 甲基(2S)-2-乙基-2,3-二氢-1-苯并呋喃-2-羧酸酯 环丙基甲胺 灭草呋喃 氘代克百威(呋喃丹) 普芦卡必利杂质H 抗氧剂136 多特林中间体 呋草黄 呋罗芬酸 呋喃酚 十一碳烯 克百威 依法克生 他司美琼 人参宁 二苯基异壬基膦酸酯 二硫代双(甲基氨基甲酸)双(2,3-二氢-2,2-二甲基-7-苯并呋喃)酯 二[2,3-二氢-2,2-二甲基-7-苯并呋喃重氮鎓]硫酸盐 二-2,3-二氢-1-苯并呋喃-5-基乙酸 乙基3-(7-溴-2,3-二氢-1-苯并呋喃-5-基)丙酸酯 丙硫克百威 丁硫克百威 [2H4]-2,3-二氢-5-苯并呋喃乙醇 [2H18]-丁硫克百威 [2-[2-氧代-5-(2,4,4-三甲基戊烷-2-基)-3H-1-苯并呋喃-3-基]-4-(2,4,4-三甲基戊烷-2-基)苯基]乙酸酯 [2,3-二氢-1-苯并呋喃-3-基(苯基)甲基]-二甲基-苯基硅烷 [2,2-二甲基-7-(甲基氨基甲酰氧基)-3H-1-苯并呋喃-3-基](Z)-2-甲基丁-2-烯酸酯 N-甲基氨基甲酸2,3-二氢苯并呋喃-7-基酯 N-甲基氨基甲酸2,3-二氢-2,2,4-三甲基苯并呋喃-7-基酯 N-甲基-[(2,3-二氢苯并[b]呋喃-7-基)甲基]胺 N-甲基(2,3-二氢苯并呋喃-2-基)甲胺盐酸盐 N-亚硝基羰基呋喃 N-[[(2S)-1-乙基吡咯烷-2-基]甲基]-5-碘-2,3-二氢-1-苯并呋喃-7-甲酰胺 N-[(2,2-二甲基-2,3-二氢-1-苯并呋喃-7-基)甲基]-n-甲胺 N-(吗啉基硫基)呋喃丹